Jasper Therapeutics receives Nasdaq delisting warning for stock price below $1.00

Filed June 9, 2026 · Period ending June 3, 2026 · ~1 min read

Key Changes

• high

  Nasdaq notified Jasper on June 3, 2026 that its stock bid price has traded below the required $1.00 minimum for 30 consecutive business days, violating listing rules. The company has until November 30, 2026 to regain compliance or face potential delisting.

  Item 3.01 verify on EDGAR →
• high

  Management is considering remediation options including a reverse stock split if the stock price doesn't naturally recover above $1.00. A reverse split would reduce share count and boost per-share price mechanically.

  Item 3.01 verify on EDGAR →
• medium

  If Jasper fails to comply by November 30, it may qualify for an additional 180-day extension, but only if it meets all other Nasdaq listing standards and commits to a reverse split if necessary.

  Item 3.01 verify on EDGAR →